Baird on Crinetics (CRNX): 'Palsonify off to a great start, expect upwards revision to estimates'
Tweet Send to a Friend
Baird analyst Brian Skorney reiterated an Outperform rating and $62.00 price target on Crinetics (NASDAQ: CRNX).The analyst comments "Palsonify off ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
